Review of updates on the prevalence and epidemiology of Acetaminophen poisoning in the United States and the United Kingdom. Njoku Amara Chiemezie.L. Researcher.

Slides:



Advertisements
Similar presentations
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Advertisements

Implementing NICE guidance
10/20/ The Pharmaceutical Industry and Their Influence on Pain Management in the ED J. David Haddox, DDS, MD VP, Risk Management & Health Policy.
Medication Management
Strategic, service provider and user responses to reducing fatal and non-fatal poisonings Rowan Williams, Development Manager, Drugaid.
Learning from Serious Case Reviews Child B.
Basics of Medication Safety
Safety Review for Plan B Daniel Davis, MD, MPH Division of Reproductive/Urologic Drugs.
Healthy People 2010 Focus Area 17: Medical Product Safety Progress Review October 19, 2007.
Objectives Why we need DHCPL Situations that call for a DHCPL Definitions DHCPL itself–content, presentation, process Target audience Current and future.
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
P HARMACY L AWS Pure Food and Drug Act Enacted to stop sale of inaccurately labeled drugs All manufacturers required to put truthful info on labels.
Dr Karen Ousey, Dr. Warren Gillibrand, Dr. John Stephenson University of Huddersfield.
Medication Management. Medications and You Know your medications and how to take them.
Homelessness and palliative care Michael Bramwell August 2014.
Chronic Pain Initiative CCNC and Project Lazarus: Chronic Pain and Community Initiative.
DSaRM Advisory Committee May 18, 2005 Active Surveillance for Drug Safety Signals: Past, Present, and Future Mary Willy, Ph.D. Division of Drug Risk Evaluation.
Medication Adherence in Heart Failure University of Central Florida Tessa Dillon.
Adverse Event Tracking as mandated by the Best Pharmaceuticals for Children Act Dr. Solomon Iyasu Medical Team Leader Division of Pediatric Drug Development.
1 One Year Post Exclusivity Adverse Event Review: Ofloxacin Ophthalmic Pediatric Advisory Committee Meeting September 15, 2004 Hari Cheryl Sachs, MD, FAAP.
What’s New! An exclusive Webinar for eHC.com Network Partners.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
Abuse Liability and Drug Scheduling: The Role of the FDA Deborah B
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
Legal and Illegal Substances Module A: Lesson 2 Grade 11 Active, Healthy Lifestyles.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Some Suggestions for FDA’s Risk Communication Strategies John Paling PhD The Risk Communication Institute A Different Perspective.
The Impact of Pharmacy Safety Alerts on Thiazolidinedione Use Lee YY 1, Chiang YC 1, Kuo LN 1, Chen HY 1,2 Department of Pharmacy, Taipei Medical University.
The Dilemma of Diclofenac Injection for the Iranian Health System Authors: Shalviri G, Cheraghali M, Gholami K, Kamali E, Daryabari N Institution: Ministry.
Nonprescription Drugs Advisory Committee Meeting Charles J. Ganley, M.D. Division of OTC Drug Products September 19, 2002.
Monday, March 21, NPPG 2015 Is there life after Codeine? Dr Helen Sammons Associate Professor of Child Health University of Nottingham Derbyshire.
Off Label Use in Managed Care Pharmacy Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
Chapter 7: Drug Information Resouces. Learning Outcomes Classify drug information request Obtain appropriate background information for drug request Distinguish.
AUGUST Is a blend of dry botanical extracts, mixed in honey and date syrup. Each botanical extract has been authorized and defined by the Israeli.
June 12, 2016 Extreme weather events and other natural hazards – the work of the HPA Professor Virginia Murray Health Protection Agency.
Information Technology Applications for Infectious Diseases and Pathogenic Microbes: A Unified Multidisciplinary Approach 康勁企業有限公司.
Off-Label Use in Managed Care Pharmacy Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016.
Introduction to general pharmacology.
Audit Opioid use in palliative patients on general hospital wards
Information on Medicinal Products
6% of adults had used one or more illicit drugs in last 12 months.
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
Opiate use in patients with inflammatory bowel disease
Risk Communication in Medicines
Neonatal Abstinence Syndrome (NAS) Program Overview
Introduction to Clinical Pharmacy
Resource use by pharmacists providing paediatric services
Understanding the Opioid Epidemic
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
Drug Information Resources
Polypharmacy In Adults: Small Test of Change
What is Soma? Carisoprodol is the generic form of the prescription drug Soma. Carisoprodol belongs to a group of drugs known as muscle relaxants. It was.
Pharmacovigilance (PV)
Opioids in Butte County
The Use and Abuse of Drugs
and Prevent 100 Million Deaths from Cardiovascular Disease
The Rising Cost of Healthcare and Potential Impact of Biosimilars
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Non-Opioids Treatment For Pain Presented By: Ashraf Al-Qaisi
Compounded Drugs and Lack of Premarket FDA-Approval
Tramadol/Paracetamol Fixed-dose Combination in the Treatment of Moderate to Severe Pain Joseph V Pergolizzi Jr, Mart van de Laar, Richard Langford, Hans-Ulrich.
Premiere Continuing Education
Cost-Efficiency of Medication Safety Program at Public Hospital, Riyadh, Saudi Arabia Yousef Ahmed Alomi, Mona Awad Alanazi, Radi Abdullah Alattyh, Fatimah.
Presentation transcript:

Review of updates on the prevalence and epidemiology of Acetaminophen poisoning in the United States and the United Kingdom. Njoku Amara Chiemezie.L. Researcher and student, Texila American University.

Summary Paracetamol was licensed for assumedly safe worldwide usage in 1955 and is debatably the most common form of pain relief, headache palliative and hyperthermia medication used in both pediatric and adult populations in the Americas

Relevance In England and Wales an estimate of over 40,000 cases of acetaminophen poisoning occurred from 1989 to 1990, (mortality of over 0.39%) Acetaminophen overdose results in more visits to emergency units in the US than overdose of any other pharmacological substance, over 50,000 emergency room visits, 2,100 hospitalizations, and over 452 deaths due to acute liver failure per year.

Background By August 2013, the United States FDA had issued a warning on the reporting of a skin dyscrasia directly linked to the drug acetaminophen as discovered by ongoing pharmacovigilance protocols. This was a side effect originally confined to allergies to non steroidal anti-inflammatory agents.FDA issues a safety alert to the public on 1st august 2013

By 14th January, 2014, FDA directed all doctors and pharmacists to desist from prescribing acetaminophen or any combined therapy of more than 325mg. Major manufacturers of acetaminophen products with dosages more than 325mg acetaminophen have stopped marketing same in the United States by 28th of March, 2014.Latest reviews as at 1st September 2015 has questioned the safety on continued use of acetaminophen as a routine pain medication during pregnancy

Methods The research method was a Meta-analysis type, collating and analyzing data from online scientific data bases, abstract guides and references, content analysis, published articles, medical textbooks and research materials from Universities.

Legislative interventions The UK parliament sought a reduction in size of paracetamol packs as an intervention to curb the rising incidence of paracetamol poisoning . The law was passed in September 1998.The research stated that there was 43% reduction in deaths associated with acetaminophen poisoning in over 11years post introduction of the legislation in the United Kingdom.

References  Gunnell D, Murray V, Hawton K (2000). "Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: worldwide patterns of use and misuse". Suicide & life-threatening behavior 30 (4): 313–26. PMID 11210057.  Hawkins LC, Edwards JN, Dargan PI (2007). "Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature". Drug safety : an international journal of medical toxicology and drug experience 30 (6): 465–79.doi:10.2165/00002018- 200730060-00002. PMID 17536874.  

Results and conclusion. The issue of acetaminophen poisoning is an ever present challenge in our world. As long as acetaminophen remains an over the counter medication around the world, the prevalence rates of its toxicity will remain alarmingly high

Results and conclusion. The pharmacovigilance protocols in the United States had received updates in emergence of new adverse effects of the drug and had issued an alert to its healthcare professionals. The United Kingdom issued a legislation which seemed to have a tremendous positive effect on the prevalence of the drug poisoning over a period of 11 years.

Thanks for your time.